Literature DB >> 21099325

Experience of islet isolation without neutral protease supplementation.

Tatsuya Kin1, Doug O'Gorman, Peter Senior, A M James Shapiro.   

Abstract

BACKGROUND: We have reported improved islet isolation outcomes using a new digestion protocol where the pancreas is perfused only with collagenase, and neutral protease (NP) is administered during the digestion phase. Since the inception of this protocol, we have had some cases where administration of NP was not required. Our new protocol was utilized in 94 islet isolations. The timing of adding NP was dependent on the progression of digestion but in 10 cases the progression was rapid and most islets in the assessment samples were free from the exocrine tissue. As a result NP was not added at all for these isolations (no-NP group). In the remaining 84 isolations, NP was added during digestion phase (control group).
RESULTS: Pancreata in the each group were digested with a similar collagenase dose. Digestion time was shorter in the no-NP (15.0±1.8 vs 19.5±0.6 min, P=0.004). At post-digestion, the no-NP had fewer trapped islets (10.9±2.8 vs 28.1±2.4%, P=0.009). Post-purification islet yield was similar (355±45 x10 ( 3) vs 318±17 x10 ( 3) IE, P=0.29). Five preparations in the no-NP were used for clinical transplantation, leading to a 64.3±15.2% reduction in insulin usage. Interestingly, cold ischemia time was longer in the no-NP (10.3±0.9 vs 7.9±0.4 h, P=0.04). One particular collagenase lot having the highest NP activity contamination was used in 7 isolations in the no-NP. Our experience indicates that supplementation of collagenase with NP is not always necessary for effective isolation. Cold ischemia time and NP contamination should be evaluated for optimal NP dosage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099325      PMCID: PMC3230559          DOI: 10.4161/isl.2.5.12602

Source DB:  PubMed          Journal:  Islets        ISSN: 1938-2014            Impact factor:   2.694


  26 in total

1.  An analysis of the role of collagenase and protease in the enzymatic dissociation of the rat pancreas for islet isolation.

Authors:  G H Wolters; G H Vos-Scheperkeuter; J H van Deijnen; R van Schilfgaarde
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

2.  Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation.

Authors:  Pascal Bucher; Zoltan Mathe; Philippe Morel; Domenico Bosco; Axel Andres; Manfred Kurfuest; Olaf Friedrich; Nicole Raemsch-Guenther; Leo H Buhler; Thierry Berney
Journal:  Transplantation       Date:  2005-01-15       Impact factor: 4.939

3.  Pancreas divisum: a study of the cadaveric donor pancreas for islet isolation.

Authors:  Tatsuya Kin; A M James Shapiro; Jonathan R T Lakey
Journal:  Pancreas       Date:  2005-05       Impact factor: 3.327

4.  Large-scale comparison of Liberase HI and collagenase NB1 utilized for human islet isolation.

Authors:  H Brandhorst; A Friberg; B Nilsson; H H Andersson; M Felldin; A Foss; K Salmela; A Tibell; G Tufveson; O Korsgren; D Brandhorst
Journal:  Cell Transplant       Date:  2009-10-09       Impact factor: 4.064

5.  Distribution of collagens type I, type III and type V in the pancreas of rat, dog, pig and man.

Authors:  J H Van Deijnen; P T Van Suylichem; G H Wolters; R Van Schilfgaarde
Journal:  Cell Tissue Res       Date:  1994-07       Impact factor: 5.249

6.  Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia.

Authors:  J R Lakey; L M Helms; T Kin; G S Korbutt; R V Rajotte; A M Shapiro; G L Warnock
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

7.  Optimization of neutral protease to collagenase activity ratio for islet of Langerhans isolation.

Authors:  P Bucher; D Bosco; Z Mathe; D Matthey-Doret; A Andres; M Kurfuerst; N Rämsch-Günther; L Bühler; P Morel; T Berney
Journal:  Transplant Proc       Date:  2004-05       Impact factor: 1.066

8.  Human islet isolation in 104 consecutive cases. Factors affecting isolation success.

Authors:  P Y Benhamou; P C Watt; Y Mullen; S Ingles; Y Watanabe; Y Nomura; C Hober; M Miyamoto; T Kenmochi; E P Passaro
Journal:  Transplantation       Date:  1994-06-27       Impact factor: 4.939

9.  Different roles of class I and class II Clostridium histolyticum collagenase in rat pancreatic islet isolation.

Authors:  G H Wolters; G H Vos-Scheperkeuter; H C Lin; R van Schilfgaarde
Journal:  Diabetes       Date:  1995-02       Impact factor: 9.461

10.  Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture.

Authors:  Masafumi Goto; Torsten M Eich; Marie Felldin; Aksel Foss; Ragnar Källen; Kaija Salmela; Annika Tibell; Gunnar Tufveson; Keisei Fujimori; Margareta Engkvist; Olle Korsgren
Journal:  Transplantation       Date:  2004-11-15       Impact factor: 4.939

View more
  11 in total

Review 1.  Enzyme Development for Human Islet Isolation: Five Decades of Progress or Stagnation?

Authors:  Daniel Brandhorst; Heide Brandhorst; Paul R V Johnson
Journal:  Rev Diabet Stud       Date:  2017-06-12

2.  The Choice of Enzyme for Human Pancreas Digestion is a Critical Factor for Increasing the Success of Islet Isolation.

Authors:  Meirigeng Qi; Luis Valiente; Brian McFadden; Keiko Omori; Shiela Bilbao; Jemily Juan; Jeffrey Rawson; Stephen Scott; Kevin Ferreri; Yoko Mullen; Mohamed El-Shahawy; Donald Dafoe; Fouad Kandeel; Ismail H Al-Abdullah
Journal:  Transplant Direct       Date:  2015-05

Review 3.  Tissue dissociation enzymes for isolating human islets for transplantation: factors to consider in setting enzyme acceptance criteria.

Authors:  Robert C McCarthy; Andrew G Breite; Michael L Green; Francis E Dwulet
Journal:  Transplantation       Date:  2011-01-27       Impact factor: 4.939

4.  Effect of Manufacturing Procedures on Human Islet Isolation From Donor Pancreata Standardized by the North American Islet Donor Score.

Authors:  Chun-Chieh Yeh; Ling-Jia Wang; James J McGarrigle; Yong Wang; Chien-Chang Liao; Mustafa Omami; Arshad Khan; Mohammad Nourmohammadzadeh; Joshua Mendoza-Elias; Benjamin McCracken; Enza Marchese; Barbara Barbaro; Jose Oberholzer
Journal:  Cell Transplant       Date:  2016-08-12       Impact factor: 4.064

5.  Effectiveness of different molecular forms of C. histolyticum class I collagenase to recover islets.

Authors:  Michael L Green; Andrew G Breite; Caleb A Beechler; Francis E Dwulet; Robert C McCarthy
Journal:  Islets       Date:  2017-09-21       Impact factor: 2.694

6.  Comparison of Clostripain and Neutral Protease as Supplementary Enzymes for Human Islet Isolation.

Authors:  Heide Brandhorst; Paul R Johnson; Johanna Mönch; Manfred Kurfürst; Olle Korsgren; Daniel Brandhorst
Journal:  Cell Transplant       Date:  2018-11-13       Impact factor: 4.064

7.  Mouse islet of Langerhans isolation using a combination of purified collagenase and neutral protease.

Authors:  Natalie D Stull; Andrew Breite; Robert McCarthy; Sarah A Tersey; Raghavendra G Mirmira
Journal:  J Vis Exp       Date:  2012-09-07       Impact factor: 1.355

8.  Clinical islet isolation outcomes with a highly purified neutral protease for pancreas dissociation.

Authors:  Doug O'Gorman; Tatsuya Kin; Rena Pawlick; Sharleen Imes; Peter A Senior; A M James Shapiro
Journal:  Islets       Date:  2013-06-11       Impact factor: 2.694

9.  Clostripain, the Missing Link in the Enzyme Blend for Efficient Human Islet Isolation.

Authors:  Magnus Ståhle; Aksel Foss; Bengt Gustafsson; Marko Lempinen; Torbjörn Lundgren; Ehab Rafael; Gunnar Tufveson; Olle Korsgren; Andrew Friberg
Journal:  Transplant Direct       Date:  2015-06-24

10.  Fluorogenic Peptide Substrate for Quantification of Bacterial Enzyme Activities.

Authors:  Ismail H Al-Abdullah; Karine Bagramyan; Shiela Bilbao; Meirigeng Qi; Markus Kalkum
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.